PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,421,422 | -24.5% | 1,681,149 | +1.4% | 0.37% | -23.5% |
| Q2 2023 | $5,853,428 | -2.3% | 1,658,195 | -14.4% | 0.49% | +17.0% |
| Q1 2023 | $5,988,692 | -6.1% | 1,938,088 | +28.5% | 0.42% | -25.1% |
| Q4 2022 | $6,377,414 | +78.7% | 1,507,663 | +0.1% | 0.56% | +80.6% |
| Q3 2022 | $3,568,521 | -12.7% | 1,505,705 | +4.9% | 0.31% | +6.2% |
| Q2 2022 | $4,089,969 | -0.3% | 1,435,077 | +0.7% | 0.29% | -7.6% |
| Q1 2022 | $4,102,992 | +20.7% | 1,424,650 | +27.4% | 0.32% | +45.2% |
| Q4 2021 | $3,398,410 | +21.8% | 1,117,898 | +180.9% | 0.22% | +11.9% |
| Q3 2021 | $2,789,559 | +467.4% | 397,940 | +583.1% | 0.19% | +59.0% |
| Q1 2020 | $491,638 | -42.9% | 58,251 | +37.7% | 0.12% | -73.8% |
| Q4 2018 | $860,825 | -13.4% | 42,301 | +95.2% | 0.47% | +6.9% |
| Q3 2018 | $993,615 | -29.8% | 21,671 | -9.4% | 0.44% | -32.6% |
| Q2 2018 | $1,415,105 | -9.3% | 23,924 | +4.4% | 0.65% | -10.8% |
| Q1 2018 | $1,559,978 | -71.1% | 22,924 | -58.1% | 0.72% | -76.7% |
| Q4 2017 | $5,402,054 | – | 54,649 | – | 3.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |